Delivery Order SPE2DB20D2104-SPE2DB23FS13Y
- Not listed
- This federal contract award is for the delivery of 90-count tablets of Donepezil HCL 23 mg, a prescription medication used to treat Alzheimer's disease. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,433.44 and an ultimate completion date of October 20, 2023. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award, valued at $541,183.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of December 12, 2024. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor for this award. The...
- This federal contract award is a $15,987.50 firm-fixed price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) on May 26, 2025. The contract has an ultimate completion date of May 27, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a delivery order with a firm fixed-price valued at $3,210.51 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support to the military services, combatant commands, and other Department of Defense components. The contract has an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price Delivery Order contract worth $1,182.71 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is for the supply of pharmaceutical products, including a 0.25% 10ML medication, to support military treatment programs and facilities. The contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $12,504.83, is a delivery order with a firm fixed price. It was awarded on April 21, 2025, with an ultimate completion date of April 22, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- This federal contract award is for a Delivery Order valued at $1,104.80, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Firm Fixed Price agreement with the Defense Logistics Agency (DLA), the agency responsible for the Defense Medical Materiel Program, to provide a variety of pharmaceutical products and medical supplies. The contract has an ultimate completion date of May 27, 2025...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $9,035.19 firm fixed price delivery order contract has an ultimate completion date of June 17, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a Ceiling Value of $2,784.18 and an Ultimate Completion Date of May 30, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract has a ceiling value of $3,258.40 and a performance period ending on July 1, 2025. Amerisourcebergen Drug Corp is delivering a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS13YDelivery Order
This contract award is for the delivery of Donepezil HCL 23 mg tablets to the Defense Logistics Agency (DLA). The $2,382.12 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 10, 2023 and was awarded on February 9, 2023. There is no set-aside designation mentioned. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as AmerisourceBergen. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award likely represents a delivery order against that larger IDC contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/9/23 |